Changye Zou
Guangzhou, Guangdong, 518010, China
NCT Number: NCT06162962
Retrospective analysis of specific characteristics of complications and long-term oncological and function outcomes in lower-limb osteosarcoma pediatric patients.
Looking for future studies?
Notify Me4 year–14 year
All sexes
Observational
Guangzhou, Guangdong, 518010, China
Clinical and functional outcomes were compared based on age groups, surgical methods, type of prosthesis, and primary tumor location. Patients were divided into the Low-age group (≤10 years old) and the High-age group (>10 years old). Overall Survival rate (OS), Progression-Free Survival rate (PFS), and prosthesis survival rate were assessed using Kaplan-Meier curves, and non-parametric survival analysis (log-rank test) was used for comparison. The incidence of complications, local relapse rate (LRR), metastasis rate, final limb-salvage and amputation rate, and Musculoskeletal Tumor Society (MSTS) score of different independent groups were further evaluated using χ2 test or Fisher's exact test, and t-test was employed to evaluate the measurement data.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Retrospective analysis
Time frame: 2000-2019
Oncological outcomes
Time frame: 2000-2019
Oncological outcomes
Time frame: 2000-2019
Oncological outcomes
Time frame: 2000-2019
Oncological outcomes
Time frame: 2000-2019
Oncological outcomes
Time frame: 2000-2019
Functional outcomes
Time frame: 2000-2019
Functional outcomes
Time frame: 2000-2019
Functional outcomes
Changye Zou
Other
Department of Orthopedic Oncology, The First Affiliated Hospital of Sun Yat-sen University
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03006848
Neoplasms, Neoplasms by Histologic Type
Los Angeles, California, United States
View Trial DetailsNCT03960177
Neoplasms, Neoplasms by Histologic Type
Jacksonville, Florida, United States
View Trial DetailsNCT04833582
Neoplasms, Neoplasms by Histologic Type
Los Angeles, California, United States
View Trial DetailsNCT02945800
Disease Attributes, Ewing Sarcoma
Birmingham, Alabama, United States
View Trial Details